Expression profile of several genes in human myometrium and uterine leiomyoma

Fertility and Sterility

Volumn 87, Issue 3, 2007, Pages 635-641

  Roth, Ted M ^a   Klett, Christoph ^b   Cowan, Bryan D ^c  

^a CENTRAL MAINE MEDICAL CENTER   (United States)

^b UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

^c UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

Author keywords

fibroid; gene expression; growth factor; heparin sulfate proteoglycan; Leiomyoma; microarray; pleiotropin; tyrosine kinase

Indexed keywords

GROWTH FACTOR; PLEIOTROPHIN;

ADULT; ARTICLE; CANCER SURGERY; CASE REPORT; CONTROLLED STUDY; CORRELATION ANALYSIS; DOWN REGULATION; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; GENETIC SCREENING; HUMAN; HUMAN TISSUE; HYSTERECTOMY; MICROARRAY ANALYSIS; MYOMETRIUM; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; UPREGULATION; UTERUS MYOMA;

ADULT; CARRIER PROTEINS; CYTOKINES; FEMALE; GENE EXPRESSION PROFILING; HUMANS; LEIOMYOMA; MIDDLE AGED; MYOMETRIUM; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; UTERINE NEOPLASMS;

EID: 33847723956     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2006.10.001     Document Type: Article

References (29)

1. Baird D.D., Dunson D.B., Hill M.C., Cousins D., and Schectman J.M. High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence. Am J Obstet Gynecol 188 (2003) 100-107
2. Rein M.S. Advances in uterine leiomyoma research: the progesterone hypothesis. Environ Health Perspect 108 (2000) 791-793
3. Lethaby A., Vollenhoven B., and Sowter M. Pre-operative GnRH analogue therapy before hysterectomy or myomectomy for uterine fibroids. Cochrane Database Syst Rev 2 (2000) CD000547
4. Murphy A.A., Kettel L.M., Morales A.J., Roberts V.J., and Yen S.S.C. Regression of uterine leiomyomata in response to the antiprogesterone RU 486. J Clin Endocrinol Metab 76 (1993) 513-517
5. Tsibris J., Segars J., Coppola D., Mane S., Wilbanks G., O'Brien W., et al. Insights from gene arrays on the development and growth regulation of uterine leiomyomata. Fertil Steril 78 (2002) 114-121
6. Chegini N., Verala J., Luo X., Xu J., and Williams R.S. Gene expression profile of leiomyoma and myometrium and the effect of gonadotropin releasing hormone analogue therapy. J Soc Gynecol Investig 10 (2003) 161-171
7. Englund K., Lindblom B., Carlstrom K., Gustavsson I., Sjoblom P., and Blanck A. Gene expression and tissue concentrations of IGF-I in human myometrium and fibroids under different hormonal conditions. Mol Hum Reprod 6 (2000) 915-920
8. Sahlin L., Wang H., Lindblom B., Eriksson H., Holmgren A., and Blanck A. Thioredoxin expression in human myometrium and fibroids. Mol Hum Reprod 6 (2000) 60-67
9. Wu X., Blanck A., Norstedt G., Sahlin L., and Flores-Morales A. Identification of genes with higher expression in human uterine leiomyomas than in the corresponding myometrium. Mol Hum Reprod 8 (2002) 246-254
10. Williams A.J., Powell W.L., Collins T., and Morton C.C. HMG(Y) expression in human uterine leiomyomata: Involvement of another high-mobility group architectural factor in a benign neoplasm. Am J Pathol 150 (1997) 911-918
11. Kim J.G., Kim M.H., Kim I.S., Moon S.Y., Kang S.B., Lee H.P., et al. Decreased expression of Mac25 mRNA in uterine leiomyomata compared with adjacent myometrium. Am J Reprod Immunol 43 (2000) 53-57
12. Noyes R.W., Hertig A.T., and Rock J. Dating the endometrial biopsy. Fertil Steril 1 (1950) 3
13. Rajeevan M.S., Vernon S.D., Taysavang N., and Unger E.R. Validation of array-based gene expression profiles by real-time (kinetic) RT-PCR. J Mol Diagn 3 (2001) 26-31
14. Englund K., Blanck A., Gustavsson I., Lundkvist U., Sjoblom P., Norgren A., et al. Sex steroid receptors in human myometrium and fibroids: changes during the menstrual cycle and gonadotropin-releasing hormone treatment. J Clin Endocrinol Metab 83 (1998) 4092-4096
15. Tsibris J.C.M., Porter K.B., Jazayeri A., Tzimas G., Nau H., Huang H., et al. Human uterine leiomyomata express higher levels of peroxisome proliferator activated receptor, retinoid X receptor alpha, and all-trans retinoic acid than myometrium. Cancer Res 59 (1999) 5737-5744
16. Tamimi Y., van der Poel H.G., Denyn N.M., Umbas R., Karthaus H.F.M., Debruyne F.M.J., et al. Increased expression of high mobility group protein I (Y) in high grade prostatic cancer determined by in situ hybridization. Cancer Res 53 (1993) 5512-5516
17. Lee B.S., and Nowak R.A. Human leiomyoma smooth muscle cells show increased expression of transforming growth factor-beta 3 (TGF beta 3) and altered responses to the antiproliferative effects of TGF beta. J Clin Endocrinol Metab 86 (2001) 913-920
18. Catherino W.H., Prupas C., Tsibris J.C., Leppert P.C., Payson M., Nieman L.K., et al. Strategy for elucidating differentially expressed genes in leiomyomata identified by microarray technology. Fertil Steril 80 (2003) 282-290
19. Wang H., Mahadevappa M., Yamamoto K., Wen Y., Chen B., Warrington J.A., et al. Distinctive proliferative phase differences in gene expression in human myometrium and leiomyomata. Fertil Steril 80 (2003) 266-276
20. Wei J.J., Chiriboga L., Arslan A.A., Melamed J., Yee H., and Mittal K. Ethnic differences in expression of the dysregulated proteins in uterine leiomyomata. Hum Reprod 21 (2006) 57-67
21. Arslan A.A., Gold L.I., Mittal K., Suen T.C., Belitskaya-Levy I., Tang M.S., et al. Gene expression studies provide clues to the pathogenesis of uterine leiomyoma: new evidence and a systematic review. Hum Reprod 20 (2005) 852-863
22. Muramatsu T. Midkine and pleiotrophin: two related proteins involved in development, survival, inflammation, and tumorigenesis. J Biochem 132 (2002) 359-371
23. Ulbricht U., Brockmann M.A., Aigner A., Eckerich C., Muller S., Fillbrandt R., et al. Expression and function of the receptor protein tyrosine phosphatase zeta and its ligand pleiotrophin in human astrocytomas. J Neuropathol Exp Neurol 62 (2003) 1265-1275
24. Deepa S.S., Yamada S., Zako M., Goldberger O., and Sugahara K. Chondroitin sulfate chains on syndecan-1 and syndecan-4 from normal murine mammary gland epithelial cells are structurally and functionally distinct and cooperate with heparan sulfate chains to bind growth factors. A novel function to control binding of midkine, pleiotrophin, and basic fibroblast growth factor. J Biol Chem 279 (2004) 37368-37376
25. Wu X., Blanck A., Olovsson M., Moller B., and Lindblom B. Expression of basic fibroblast growth factor (bFGF), FGF receptor 1 and FGF receptor 2 in uterine leiomyomas and myometrium during the menstrual cycle, after menopause and GnRHa treatment. Acta Obstet Gynecol Scand 80 (2001) 497-504
26. Barbarisi A., Petillo O., Di Lieto A., Melone M.A., Margarucci S., Cannas M., et al. 17-Beta estradiol elicits an autocrine leiomyoma cell proliferation: evidence for a stimulation of protein kinase-dependent pathway. J Cell Physiol 186 (2001) 414-424
27. Qin L.X., and Tang Z.Y. The prognostic molecular markers in hepatocellular carcinoma. World J Gastroenterol 8 (2002) 385-392
28. Aigner A., Brachmann P., Beyer J., Jager R., Raulais D., Vigny M., et al. Marked increase of the growth factors pleiotrophin and fibroblast growth factor-2 in serum of testicular cancer patients. Ann Oncol 14 (2003) 1525-1529
29. Barthlen W., Flaadt D., Girgert R., Conzelmann J., Schweizer P., Zugmaier G., et al. Significance of heparin-binding growth factor expression on cells of solid pediatric tumors. J Pediatr Surg 38 (2003) 1296-1304